Introduction
As previously outlined in JICS, 1 the NIHR Clinical Research Networks (CRNs) were created in 2006 to improve the health and wealth of the nation through research. The new research funding system has revolutionised the organisation of clinical research in intensive care through funding support services (pharmacy, pathology and radiology) and research nurses, together with establishing consultant clinical champions and local principal investigators for multicentre studies. This has resulted in phenomenal growth in NIHR portfolio study activity in Cumbria and Lancashire since our CLRN was established as one of 25 CLRNs in 2007/2008 (Figure 1 and 2) .
Cumbria and Lancashire
The geography of our region presents unique challenges to delivery of portfolio studies. Cumbria, home to the Lake District, is a non-metropolitan county, and the third largest by area, with a population of just under half a million, making it one of the most sparsely populated counties in the UK (73.4 people per km 2 ). Lancashire, which is also a non-metropolitan county in the North West of England, has a population of almost 1.5 million people. The Cumbria and Lancashire (C&L) CLRN therefore covers a combined population of nearly 2 million people spread over a large geographical area (over 100 miles between the acute Trusts in the far north and south of this CLRN).
The region has five acute NHS Trusts, comprising eight acute hospitals with intensive care facilities ( The impact of the National Institute for Health Research on regional intensive care research: a case study from Cumbria and Lancashire
A Krige
This article illustrates the regional experience of participation in research following the introduction of the National Institute for Health Research (NIHR) Comprehensive Local Research Networks (CLRNs) and the Critical Care Specialty Groups. Prior to this, research was focused in academic centres and tertiary hospitals. Clinicians in smaller regional hospitals had little opportunity or support to participate in clinical trials or other important studies. CLRNs were introduced to ensure that NHS research funding is spread widely throughout the NHS, ensuring all patients can potentially benefit from participation. This maximises research efficiency and results are likely to be more generalisable to the whole NHS, which may lead to wider and more rapid translation of positive studies into clinical practice. This region has no large university medical schools, Biomedical Research Centres or Units, biotechnology companies or life sciences industry. Previously, we were hampered by a lack of emphasis on research by local NHS organisations; there were no clinical academics and limited recognition of research time in consultant contracts. Furthermore, there was little means of funding or appointing research nurses in order to participate in multicentre investigator-or commercial-sponsored research. Despite the presence of enthusiastic individual clinicians, participation in clinical research was extremely difficult, if not impossible, until the advent of NIHR CLRN support.
Local CLRN infrastructure
The host organisation for Cumbria and Lancashire CLRN is Lancashire Teaching Hospitals and the CLRN management team is based in Preston. When the CLRN was established, anaesthesia and intensive care were combined as one specialty group, with an academic anaesthetist as convener. With time, it became apparent to the CLRN that all the research activity was in intensive care and very little in anaesthesia, due to the nature of the portfolio. In fact intensive care and reproductive 
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For local researchers/PIs
• Satisfaction in contributing to the success of important large multicentre studies
• Networking with like-minded research active colleagues locally, regionally (CLRN meetings) and nationally (the UKCCTF and the Specialty Group)
• Exposure to major studies and observing how large studies are designed which they can put into practice in submitting their own grant applications Table 2 The benefits of involvement with portfolio studies. medicine were responsible for over 90% of all accruals to studies in Cumbria and Lancashire, the bulk of this recruitment occurring at Royal Blackburn Hospital and Royal Preston Hospital where this author, and the co-convener, Shond Laha, were respective research leads. This led to an invitation from the CLRN Director to become co-conveners for a new intensive care specialty group in August 2010.
Since then, we have held meetings twice a year at the CLRN with the ICU research leads and research nurses. Apart from updating the group on new and upcoming studies on the portfolio, which may be of interest, and presenting new national developments, it has proven fruitful for discussing common problems with recruitment and learning from each other. We acquire regular updates of accrual to all studies directly from each of the sites, distributing this to provide healthy competition. Direct lines of communication are opened when it is apparent there are recruitment problems with a particular study to see if any advice or support can be provided. Any calls for new sites to studies, commercial or non-commercial, are rapidly disseminated through our network. Study feasibility questionnaires are forwarded to us for completion and we take part in portfolio adoption decisions with other SG members.
Several different research nurse models are in place and each has proven successful in respective units. They range from a traditional model of a dedicated intensive care research nurse to a more generic research nurse covering multiple specialties (usually anaesthesia, emergency medicine and intensive care) and a third model that I introduced in my own unit, which has worked well for us. We seconded three of our intensive care nurses to share one WTE intensive care research nurse post and provided them with research training. They start their day with a research session and then move over into their clinical
Special article For local researchers/PIs
Portfolio study examples from our CLRN
• In an era when supporting professional activity is increasingly under threat research is recognised as such activity within job planning
• Research activity, and the CPD gained from studies and study meetings, satisfies many appraisal domains, which is of increased importance now that revalidation has begun shifts. This model has many advantages, ie they are all highly skilled clinically (very useful for more complex interventional studies, eg high frequency oscilatory ventilation (HFOV); they are well known and respected clinically (this has accelerated the creation of a research culture and ethos making research part of usual business); and they have the opportunity to provide ongoing staff education, maintain awareness of potential recruits and often nurse the study patients on their clinical shift. Virtually all units in our region have participated in at least one portfolio study to date, and three sites are highly active ( Table 1) .
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Top tip Outputs and examples
Present the protocol early to all stakeholders. Ensure equipoise, buy-in, identify obstacles, specific training needs and agree a treatment pathway Active PI Essential to support the research nurses and champion the study to colleagues PI availability Mobile contact for interventional studies with short recruitment windows. Early advice if problems and initial consent and randomisation by telephone if necessary Clinical staff education regarding study eligibility and screening For example, early in the CALORIES trial potential recruitment was lost due to enteral feeding being started immediately after ventilation; education has ensured that start of feeding on potential CALORIES trial patients is paused until screening has occurred 
Why get involved with portfolio studies? The benefits
There are numerous benefits of being involved in research which are summarised in Table 2 , but as a specific example, participation in the OSCAR Study of HFOV compared to conventional ventilation in acute respiratory distress syndrome (ARDS) resulted in closer attention to protective lung ventilation in the control arm, education and training in using a new technology and related medical educational opportunities.
What are the challenges to continued successful accrual to NIHR portfolio studies?
Following a period of provision of new resource and rapid successful accrual to intensive care studies, several new challenges are emerging in consolidating and maintaining our activity. For example, some ICUs are starting to experience saturation of their research population, and competition for recruitment among similar patient populations. When this occurs, we have concerns about selection bias as a result of differing eligibility criteria, achieving monthly recruitment targets and the timing of eligibility during ICU stay. We have also found that support services, such as pharmacy, are sometimes unable to provide resources such as drug storage or pathology laboratories sample storage. Following a period of injection of new resource for research nurse funding, ongoing funding is increasingly in high demand as research activity has increased across the entire NIHR research network and different specialty groups. Strong cases for future funding are needed based on maintaining activity and participating in new portfolio studies. As many CLRNs are now research active in intensive care, there is increasing competition for all new multicentre projects.
Much of the work involved in setting up and delivering studies falls to consultants in non-academic hospitals, where research fellows are rare and senior trainees do not have academic time. This is especially the case for clinical trial of an investigational medicinal product (CTIMP) trials, or studies of complex interventions, both of which require significant staff training. This is increasingly challenging at a time of pressure on supporting activities within job plans.
Lessons learnt and top tips for successful recruitment
As complete novices three years ago we have learnt many lessons the hard way. A list of top tips along with the related outputs or examples are presented in Table 3 . This may help others avoid these potential pitfalls.
The future
Our strengths are consistently delivering high accrual rates to studies and very short R&D approval times. We will use this to attract further non-commercial and commercial studies to Cumbria and Lancashire. We strive to offer every patient admitted to our ICUs the opportunity to benefit from participation in a clinical trial, and where appropriate, multiple studies and aim to have all intensive care clinicians complete GCP training allowing them to contribute to the research process. A Principal Investigator (PI) study day is being designed locally and more colleagues will be encouraged to consider taking on the PI role for studies so the workload is shared. An intensive care trials group is being established in the region to develop our own research ideas and in time, grant applications, which will allow us more control over the portfolio and accrual locally.
Conclusions
Areas of the UK not previously active in research such as Cumbria and Lancashire, have demonstrated that we have a large previously untapped research population willing to participate in research, and a healthcare workforce able to deliver on studies. The C&L CLRN Critical Care Specialty Group has proven extremely successful and the accrual rates in all our hospitals make us indispensable to the CLRN. We hope that this will lead to continued growth in our research capacity and locally generated studies adopted onto the portfolio.
